Telomir Pharmaceuticals I... (TELO)
NASDAQ: TELO
· Real-Time Price · USD
1.27
0.09 (7.63%)
At close: Sep 04, 2025, 11:30 AM
Telomir Pharmaceuticals Common Stock Cash Flow Statement
Financials in USD. Fiscal
year is
undefined.
| Fiscal Year | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 | Q2 2022 | Q1 2022 |
| Period Ending | Jun 30, 2025 | Mar 31, 2025 | Dec 31, 2024 | Sep 30, 2024 | Jun 30, 2024 | Mar 31, 2024 | Dec 31, 2023 | Sep 30, 2023 | Jun 30, 2023 | Mar 31, 2023 | Dec 31, 2022 | Sep 30, 2022 | Jun 30, 2022 | Mar 31, 2022 |
Net Income | -5.07M | -2.18M | -2.9M | -5.93M | -1.45M | -6.25M | -9.33M | -1.71M | -1.55M | -482.94K | -487.1K | -233.5K | -70.06 | -66.78 |
Depreciation & Amortization | n/a | n/a | n/a | n/a | n/a | 4.34M | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Stock-Based Compensation | 4.66M | 1.38M | 2.06M | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Other Working Capital | 12.9K | -30.32K | 19.47K | 10.47K | 10.99K | -98.09K | 250.00 | -963 | 1.39M | n/a | n/a | n/a | n/a | n/a |
Other Non-Cash Items | n/a | -28.68K | 130K | 4.81M | -84.83K | 4.34M | 730.23K | 757.17K | 124.05K | -252.8 | -231.31K | -151.1K | 4.83 | 1.54 |
Deferred Income Tax | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Change in Working Capital | -291K | -30.32K | 100.53K | 123.13K | 10.99K | -23.35K | 23K | -1.05M | 1.39M | -252.8K | 231.31K | 151.1K | n/a | n/a |
Operating Cash Flow | -696.45K | -863.13K | -605.81K | -1M | -1.52M | -1.94M | -1.09M | -2M | -33.58K | -735.74K | -255.79K | -82.39K | -65.24 | -65.24 |
Capital Expenditures | 4.00 | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Cash Acquisitions | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Purchase of Investments | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Sales Maturities Of Investments | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Other Investing Acitivies | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Investing Cash Flow | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Debt Repayment | n/a | n/a | 101K | -132.44K | 132.44K | -101K | 1.07M | 1.56M | 487.91K | n/a | n/a | 80K | n/a | n/a |
Common Stock Repurchased | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Dividend Paid | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Other Financial Acitivies | n/a | n/a | 6.77M | 85.53K | 132.44K | -519.48K | -70.39K | 429.81K | 136.4K | -263.87K | 195.88K | n/a | 69.60 | 69.60 |
Financial Cash Flow | 1.05M | n/a | 1.04M | -46.91K | 132.44K | 5.21M | 1.09M | 1.99M | 46.4K | 736.13K | 250.88K | 80K | 69.60 | 69.60 |
Net Cash Flow | 351.32K | -863.13K | 431.49K | -1.05M | -1.39M | 3.27M | -1.22K | -12.18K | 12.82K | 388.00 | 1.41K | -2.4K | n/a | n/a |
Free Cash Flow | -696.45K | -863.13K | -605.81K | -1M | -1.52M | -1.94M | -1.09M | -2M | -33.58K | -735.74K | -255.79K | -82.39K | -65.24 | -65.24 |